-
Événement | 2022.10.28
A bicentenary tribute to Louis Pasteur, Foreign Member of the Royal Society
To celebrate the bicentenary of Louis Pasteur's birth and pay tribute to this scientist who was a Foreign Member of the Royal Society, the Institut Pasteur and the Académie des sciences are organizing a symposium with support from the Royal Society. This symposium will present cutting-edge research in Louis Pasteur’s own research areas and promote international cooperation in science and...
-
News | 2022.11.24
From bacterial poisons to toxins: the early work of the Pasteurians
Jean-Marc Cavaillon, Honorary Professor at the Institut Pasteur, presents an overview of the discoveries that have shaped our understanding of bacterial toxins.
-
News | 2024.12.09
Lessons learned from the COVID-19 crisis: improving protection through early response, rapid tracking and impact monitoring
Scientific experts from 13 Western European countries have recently completed a review of key lessons learned from the way the COVID-19 pandemic was handled. Two key findings have emerged. Firstly, death rates were lower in countries that took measures early. Secondly, the need for a surveillance system capable of quickly tracking the community spread of a virus and its impact on hospitals was...
-
Document de presse | 2012.02.09
Newly characterized dengue virus antibody shows promise
Research teams from the Institut Pasteur, the CNRS, and Inserm have recently characterized the structure and mechanism of action of an antibody that successfully neutralizes all four strains of the dengue virus in mice models. Their groundbreaking work represents major progress for research efforts that hope to develop an effective vaccine to combat this disease. This study was published February...
-
Document de presse | 2007.07.12
Leptospirosis: the first virulence gene identified
Although leptospirosis is one of the so-called "neglected" diseases, it still causes some 500,000 severe cases in humans around the world each year and also comprises a veterinary problem. A century after the pathogenic agent that causes the disease was found, researchers at the Institut Pasteur have discovered a gene that is essential to the bacteria's virulence. Their work,...
-
Document de presse | 2005.02.24
"The Sword and the Shield" - How bacteria develop their virulence by creating multiple variants
Researchers at Institut Pasteur and the French National Institute of Health and Medical Research (Inserm), in association with the Imperial College of London, recently explained why Shigella flexneri bacteria, which cause fatal dysenteries, have several variants (serotypes), thus optimizing their virulence. This discovery, published in Science, is essential to vaccine research as, in order to be...
-
News | 2018.11.14
130 years ago, the Institut Pasteur opened its doors for the first time
The Institut Pasteur, set up following the success of the human rabies vaccination with funds from a public appeal launched by the French Academy of Sciences, was officially opened 130 years ago, on November 14, 1888, at a ceremony attended by the French President Sadi Carnot and several other prestigious guests. We look back on a day that "would go down in the history of medicine".*A huge crowd...
-
News | 2018.12.17
WHO high-level meeting on preparedness in public health emergencies
On December 4th, The Institut Pasteur International Network (IPIN) participated in a high-level meeting on preparedness in public health emergencies and the challenges and opportunities in urban areas organized by World Health Organization (WHO) in Lyon.The objective of this conference was to identify gaps and challenges, to foster intersectoral and multidisciplinary collaboration (including a "...
-
Article | 2020.06.16
Randomized trial of Covid-19 chemoprophylaxis in healthcare professionals
Objective: To determine whether a two months treatment with hydroxychloroquine (HCQ) or Lopinavir / ritonavir (LPV / r) reduces the incidence of symptomatic or asymptomatic infections with SARS-CoV-2, compared to their placebo, in healthcare professionals exposed to the virus.In the absence of specific antiviral treatment, particular attention must be paid to prevention. Individual protective...
-
News | 2023.09.05
HIV-AIDS: broadly neutralizing antibodies, stars of the lab
Highly promising, broadly neutralizing antibodies can react with the vast majority of HIV particles to cause their destruction by the body. However, the latter would have to be able to produce equally effective antibodies...